Cargando…
Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM
Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was establishe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076571/ https://www.ncbi.nlm.nih.gov/pubmed/37033649 http://dx.doi.org/10.3389/fphar.2023.1075010 |
_version_ | 1785020156504702976 |
---|---|
author | Zan, Ke Wang, Zhao Hu, Xiao-Wen Li, Yao-Lei Wang, Ying Jin, Hong-Yu Zuo, Tian-Tian Ma, Shuang-Cheng |
author_facet | Zan, Ke Wang, Zhao Hu, Xiao-Wen Li, Yao-Lei Wang, Ying Jin, Hong-Yu Zuo, Tian-Tian Ma, Shuang-Cheng |
author_sort | Zan, Ke |
collection | PubMed |
description | Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was established to simultaneously determine eight pyrrolizidine alkaloids (PAs), namely intermedine, lycopsamine, intermedine N-oxide, lycopsamine N-oxide, 7-acetyllycopsamine, 7-acetyllycopsamine N-oxide, echimidine N-oxide, and echimidine in the three herbs. Based on these results, the risk assessment was explored using the routine margin of exposure (MOE) combined with relative potency (REP) for oral and external usage, respectively. Results and Conclusion: Imermedine and imermedine N-oxide were common components in the eight tested PAs. 7-acetyllycopsamine and its N-oxide were not detected in AE; echimidine and its N-oxide were not detected in AG; lycopsamine and its N-oxide, 7-acetyllycopsamine and its N-oxide were not detected in LE. The total contents of 8 PAs in 11 batches of AG was341.56–519.51 μg/g; the content in 15 batches of LE was 71.16–515.73 μg/g, and the content in 11 batches of AE was 23.35–207.13 μg/g. Based on these results, the risk assessment was explored using MOE combined with REP for oral and external usage, respectively. The findings of the risk assessment method of PAs based on MOE combined with the REP factor were consistent with the clinical toxicity results. As an oral herb, AE had low risk or no risk due to its low PA contents, and individual batches of LE were medium risk, while attention should be paid to their clinical use.AG was also low risk. The external use of the three Boraginaceae used in TCM was not associated with any risk. This study systematically explored the PA type and content of the three Boraginaceae used in TCM. Additionally, the refined risk assessment of PAs based on REP provided a more scientific basis for quality evaluation and rational use of the medicinal Boraginaceae used in TCM to improve public health. |
format | Online Article Text |
id | pubmed-10076571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100765712023-04-07 Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM Zan, Ke Wang, Zhao Hu, Xiao-Wen Li, Yao-Lei Wang, Ying Jin, Hong-Yu Zuo, Tian-Tian Ma, Shuang-Cheng Front Pharmacol Pharmacology Objective: The aim of this study was to systematically explore the pyrrolizidine alkaloids (PAs) type, content and risk assessment in the three Boraginaceae used in TCM, involving Arnebia euchroma (AE), A. guttata (AG), and Lithospermum erythrorhizon (LE). Method: A UHPLC–MS/MS method was established to simultaneously determine eight pyrrolizidine alkaloids (PAs), namely intermedine, lycopsamine, intermedine N-oxide, lycopsamine N-oxide, 7-acetyllycopsamine, 7-acetyllycopsamine N-oxide, echimidine N-oxide, and echimidine in the three herbs. Based on these results, the risk assessment was explored using the routine margin of exposure (MOE) combined with relative potency (REP) for oral and external usage, respectively. Results and Conclusion: Imermedine and imermedine N-oxide were common components in the eight tested PAs. 7-acetyllycopsamine and its N-oxide were not detected in AE; echimidine and its N-oxide were not detected in AG; lycopsamine and its N-oxide, 7-acetyllycopsamine and its N-oxide were not detected in LE. The total contents of 8 PAs in 11 batches of AG was341.56–519.51 μg/g; the content in 15 batches of LE was 71.16–515.73 μg/g, and the content in 11 batches of AE was 23.35–207.13 μg/g. Based on these results, the risk assessment was explored using MOE combined with REP for oral and external usage, respectively. The findings of the risk assessment method of PAs based on MOE combined with the REP factor were consistent with the clinical toxicity results. As an oral herb, AE had low risk or no risk due to its low PA contents, and individual batches of LE were medium risk, while attention should be paid to their clinical use.AG was also low risk. The external use of the three Boraginaceae used in TCM was not associated with any risk. This study systematically explored the PA type and content of the three Boraginaceae used in TCM. Additionally, the refined risk assessment of PAs based on REP provided a more scientific basis for quality evaluation and rational use of the medicinal Boraginaceae used in TCM to improve public health. Frontiers Media S.A. 2023-03-23 /pmc/articles/PMC10076571/ /pubmed/37033649 http://dx.doi.org/10.3389/fphar.2023.1075010 Text en Copyright © 2023 Zan, Wang, Hu, Li, Wang, Jin, Zuo and Ma. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Zan, Ke Wang, Zhao Hu, Xiao-Wen Li, Yao-Lei Wang, Ying Jin, Hong-Yu Zuo, Tian-Tian Ma, Shuang-Cheng Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title | Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title_full | Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title_fullStr | Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title_full_unstemmed | Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title_short | Pyrrolizidine alkaloids and health risk of three Boraginaceae used in TCM |
title_sort | pyrrolizidine alkaloids and health risk of three boraginaceae used in tcm |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076571/ https://www.ncbi.nlm.nih.gov/pubmed/37033649 http://dx.doi.org/10.3389/fphar.2023.1075010 |
work_keys_str_mv | AT zanke pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT wangzhao pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT huxiaowen pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT liyaolei pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT wangying pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT jinhongyu pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT zuotiantian pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm AT mashuangcheng pyrrolizidinealkaloidsandhealthriskofthreeboraginaceaeusedintcm |